U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Information on Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics)
  1. Postmarket Drug Safety Information for Patients and Providers

Information on Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics)

To report any serious adverse events associated with the use of these products, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Labeling and Regulatory History from Drugs@FDA

Back to Top